Table 4.
The risk of reduced FVC according to NAFLD and relative hand grip strength-based subgroups.
| Crude Model | Model 1 | Model 2 | Model 3 | |||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | p-Value | OR (95% CI) | p-Value | OR (95% CI) | p-Value | OR (95% CI) | p-Value | |
| Total (n = 1651) | ||||||||
| Normal + High HGS | 1 | 1 | 1 | 1 | ||||
| NAFLD + High HGS | 1.297 (0.67–2.50) |
0.436 | 1.443 (0.74–2.81) |
0.281 | 1.455 (0.75–2.84) |
0.271 | 1.398 (0.70–2.76) |
0.341 |
| Normal + Low HGS | 3.062 (2.46–4.83) |
<0.001 | 1.990 (1.38–2.87) |
<0.001 | 2.017 (1.39–2.92) |
<0.001 | 2.036 (1.40–2.97) |
<0.001 |
| NAFLD + Low HGS | 4.489 (3.43–7.09) |
<0.001 | 3.606 (2.46–5.29) |
<0.001 | 3.581 (2.43–5.27) |
<0.001 | 3.390 (2.23–5.15) |
<0.001 |
| Non-obese (n = 1042) | ||||||||
| Normal + High HGS | 1 | 1 | 1 | 1 | ||||
| NAFLD + High HGS | 1.923 (0.42–8.73) |
0.397 | 1.881 (0.41–8.69) |
0.419 | 1.937 (0.42–8.97) |
0.398 | 1.674 (0.35–8.02) |
0.519 |
| Normal + Low HGS | 4.055 (2.62–6.27) |
<0.001 | 2.339 (1.44–3.79) |
0.001 | 2.454 (1.51–4.00) |
<0.001 | 2.480 (1.51–4.07) |
<0.001 |
| NAFLD + Low HGS | 6.396 (2.72–15.07) |
<0.001 | 4.160 (1.70–10.16) |
0.002 | 4.274 (1.74–10.48) |
0.002 | 3.856 (1.49–9.99) |
0.005 |
| Obese (n = 609) | ||||||||
| Normal + High HGS | 1 | 1 | 1 | 1 | ||||
| NAFLD + High HGS | 1.251 (0.68–2.31) |
0.473 | 1.619 (0.85–3.10) |
0.146 | 1.550 (0.80–2.99) |
0.285 | 1.536 (0.78–3.01) |
0.211 |
| Normal + Low HGS | 2.550 (1.36–4.77) |
0.003 | 1.533 (0.78–3.01) |
0.215 | 1.457 (0.73–2.90) |
0.191 | 1.398 (0.68–2.86) |
0.358 |
| NAFLD + Low HGS | 2.568 (1.46–4.51) |
0.001 | 2.247 (1.23–4.11) |
0.008 | 2.289 (1.25–4.19) |
0.007 | 2.192 (1.15–4.16) |
0.017 |
OR: odd ratio, CI: confidence interval, NAFLD: non-alcoholic fatty liver disease, HGS: hand grip strength; crude model: unadjusted; model 1: adjusted for age, sex; model 2: adjusted for age, sex, smoking; model 3: adjusted for age, sex, smoking, FBG, HDL-C, TG, SBP, DBP, CRP, alcohol consumption.